Literature DB >> 8962190

Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis.

R R Bartlett1, S Brendel, T Zielinski, H U Schorlemmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8962190

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Leflunomide: new antirheumatic drug. Effect on pregnancy outcomes.

Authors:  E Kozer; M E Moretti; G Koren
Journal:  Can Fam Physician       Date:  2001-04       Impact factor: 3.275

2.  The mammalian homologue of Prp16p is overexpressed in a cell line tolerant to Leflunomide, a new immunoregulatory drug effective against rheumatoid arthritis.

Authors:  D Ortlepp; B Laggerbauer; S Müllner; T Achsel; B Kirschbaum; R Lührmann
Journal:  RNA       Date:  1998-08       Impact factor: 4.942

3.  Nimesulide improves the symptomatic and disease modifying effects of leflunomide in collagen induced arthritis.

Authors:  Ahmed M Al-Abd; Fahad A Al-Abbasi; Salwa M Nofal; Amani E Khalifa; Richard O Williams; Wafaa I El-Eraky; Ayman A Nagy; Ashraf B Abdel-Naim
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.